Novel biodegradable blend matrices for controlled drug release

Journal of Pharmaceutical Sciences

Volumn 97, Issue 10, 2008, Pages 4240-4248

  Lin, Mei ^a,b   Meng, Sheng ^a   Zhong, Wei ^a   Li, Zhulai ^b   Du, Qiangguo ^a   Tomasik, Piotr ^c  

^a FUDAN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF AGRICULTURE IN KRAKOW   (Poland)

Author keywords

Biodegradable polymers; Controlled release; Ibuprofen; Phosphorylcholine; Poly caprolactone

Indexed keywords

IBUPROFEN; PHOSPHORYLCHOLINE; POLYCAPROLACTONE; POLYMER;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED RELEASE FORMULATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DEGRADATION; DRUG RELEASE; HYDROPHILICITY; MOLECULAR WEIGHT; WATER TRANSPORT; X RAY DIFFRACTION;

EID: 55749103392     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21297     Document Type: Article

References (37)

1. Lewis KJ, Irwin WJ, Akhtar S. 1995. Biodegradable poly (L-lactic acid) matrices for the sustained delivery of antisense oligonucleotides. J Control Release 37:173-183.
2. Tian D, Dubois P, Jerome R. 1996. A new poly (ε-caprolactone) containing hybrid ceramer prepared by the sol-gel process. Polymer 37:3983-3987.
3. Mu L, Feng SS. 2003. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS. J Control Release 86:33-48.
4. Berkland C, Kipper MJ, Narasimhan B, Kim K, Pack DW. 2004. Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres. J Control Release 94:129-141.
5. Kumar N, Langer RS, Domb AJ. 2002. Polyanhydrides: An overview. Adv Drug Deliver Rev 54:889-910.
6. Kim JH, Bae YH. 2004. Albumin loaded microsphere of amphiphilic poly (ethylene glycol)/ poly(α-ester) multiblock copolymer. Eur J Pharm Sci 23:245-251.
7. Kim HW, Knowel JC, Kim HE. 2004. Development of hydroxyapatite bone scaffold for controlled drug release via poly (epsilon-caprolactone) and hydroxyapatite hybrid coatings. J Biomed Mater Res B 70B:240-249.
8. Liu L, Li Y, Liu H, Fang Y. 2004. Synthesis and characterization of chitosan-graft-polycaprolactone copolymers. Eur Polym J 40:2739-2744.
9. Jeong JC, Lee J, Cho K. 2003. Effects of crystalline microstructure on drug release behavior of poly (epsilon-caprolactone) microspheres. J Control Release 92:249-298.
10. Barbato F, La Rotonda MI. 2001. Biodegradable microspheres of novel segmented poly(ether-esteramide) s based on poly(ε-caprolactone) for the delivery of bioactive compounds. Biomaterials 22:1371-1378.
11. Kim MS, Seo KS, Hyun H, Khang G, Cho SH. 2006. Controlled release of bovine serum albumin using MPEG-PCL diblock copolymers as implantable protein carriers. J Appl Polym Sci 102:1561-1567.
12. Das GS, Rao GHR, Wilson RF, Chandy T. 2000. Colchicine encapsulation within poly (ethylene glycol)-coated poly (lactic acid)/poly (epsilon-caprolactone) microspheres-controlled release studies. Drug Deliv 7:129-138.
13. Ha JC, Kim SY, Lee YM. 1999. Poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) (Pluronic)/Poly (ε-caprolactone) (PCL) amphiphilic block copolymeric nanospheres. I. Preparation and characterization. J Control Release 62:381-392.
14. Zhang L, Hu Y, Jiang X, Yang C, Lu W, Yang YH. 2004. Camptothecin derivative-loaded poly (caprolactone-co-lactide)-b-PEG-b-poly (caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J Control Release 96:135-148.
15. Tarvainen T, Karjalainen T, Malin M, Perakorpi K, Tuominen J, Seppala J, Jarvinen K. 2002. Drug release profiles from and degradation of a novel biodegradable polymer, 2,2-bis (2-oxazoline) linked poly (ε-caprolactone). Eur J Pharm Sci 16:323-331.
16. Ciardelli G, Chiono V, Vozzi G, Pracella M, Ahluwalia A, Barbani N, Cristallini C, Giusti P. 2005. Blends of poly-(ε-caprolactone) and polysaccharides in tissue engineering applications. Biomacromolecules 6:1961-1976.
17. Shen Y, Sun W, Zhu KJ, Shen Z. 2000. Regulation of biodegradability and drug release behavior of aliphatic polyesters by blending. J Biomed Mater Res 50:528-535.
18. Cai Q, Bei J, Wang S. 2002. In vitro study on the drug release behavior from polylactide-based blend matrices. Polym Advan Technol 13:534-540.
19. Murphy EF, Lu JR, Brewer J, Russell J, Penfold J. 1999. The reduced adsorption of proteins at the phosphorylcholine incorporated polymer-water interface. Langmuir 15:1313-1322.
20. Uchiyama T, Watanabe J, Ishihara K. 2002. Biocompatible polymer alloy membrane for implantable artificial pancreas. J Membrane Sci 208:39-48.
21. Nederberg F, Bowden T, Hilborn J. 2004. Synthesis, characterization, and properties of phosphorylcholine functionalized poly (epsilon-caprolactone) and charged phospholipid analogues. Macromolecules 37:954-965.
22. Ishihara K, Nomura H, Mihara T, Kurita K, Iwasaki Y, Nakabayashi N. 1998. Why do phospholipid polymers reduce protein adsorption? J Biomed Mater Res 39:323-330.
23. Hasegawa T, Iwasaki Y, Ishihara K. 2002. Preparation of blood-compatible hollow fibers from a polymer alloy composed of polysulfone and 2-methacryloyloxyethyl phosphorylcholine polymer. J Biomed Mater Res 63:333-341.
24. Guiseppi-Elie A, Brahim S, Slaughter G, Ward KR. 2005. Design of a subcutaneous implantable biochip for monitoring of glucose and lactate. IEEE Sensors J 5:345-355.
25. Salvage JP, Rose SF, Phillips GJ, Hanlon GW, Lloyd AW, Ma IY, Armes SP, Billingham NC, Lewis /SNM>AL. 2005. Novel biocompatible phosphorylcholine- based self-assembled nanoparticles for drug delivery. J Control Release 104:259-270.
26. Xu JP, Ji J, Shen JC. 2005. Novel biomimetic polymersomes as polymer therapeutics for drug delivery. J Control Release 107:502-512.
27. Palmer RR, Lewis AL, Kirkwood LC, Rose SF, Lloyd AW, Vick TA, Stratford PW. 2004. Biological evaluation and drug delivery application of cationically modified phospholipid polymers. Biomaterials 25:4785-4796.
28. Meng S, Zhong W, Chou LL, Wang Q, Liu ZJ, Du QG. 2007. Phosphorylcholine end-capped poly-e-caprolactone: A novel biodegradable material with improved antiadsorption property. J Appl Polym Sci 103:989-997.
29. Chao GT, Fan LY, Jia WJ, Qian ZY, Gu YC, Liu CB, Ni XP, Li J, Deng HX, Gong CY, Gou MY, Lei K, Huang AL, Huang CH, Yang JL, Kan B, Tu MJ. 2007. Synthesis, characterization and hydrolytic degradation of degradable poly(butylene terephthalate)/ poly(ethylene glycol) (PBT/PEG) copolymers. J Mater Sci, Mater Med 18:449-455.
30. Qian ZY, Li S, He Y, Liu XB. 2004. Synthesis and in vitro degradation study of poly(ethylene terephthalate)/poly(ethylene glycol) (PET/PEG) multiblock copolymer. Polym Degrad Stabil 83:93-100.
31. Wu LB, Ding JD. 2004. In vitro degradation of three-dimensional porous poly (d, l-lactide-coglycolide) scaffolds for tissue engineering. Biomaterials 25:5821-5830.
32. Xue JM, Shi M. 2004. PLGA/mesoprous silica hybrid structure for controlled drug release. J Control Release 98:209-217.
33. Seo S, Choi HS, Khang G, Rhee JM, Lee HB. 2002. A local delivery system for fentanyl based on biodegradable poly (L-lactide-co-glycolide) oligomer. Int J Pharm 239:93-101.
34. Frank A, Rath SK, Venkatraman SS. 2005. Controlled release from bioerodible polymers: Effect of drug type and polymer composition. J Control Release 102:333-344.
35. Siepmann J, Peppas NA. 2001. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliver Rev 48:139-157.
36. Zuleger S, Lippold BC. 2001. Polymer particle erosion controlling drug release: I. Factors influencing drug release and characterization of the release mechanism. Int J Pharm 217:139-152.
37. Xiong XY, Tam KC, Gan LH. 2005. Release kinetics of hydrophobic and hydrophilic model drugs from pluronic F127/poly (lactic acid) nanoparticles. J Control Release 103:73-82.